Ethan Lange
Concepts (675)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Prostatic Neoplasms | 43 | 2016 | 925 | 3.630 |
Why?
| Polymorphism, Single Nucleotide | 64 | 2023 | 1892 | 3.170 |
Why?
| Genetic Linkage | 41 | 2012 | 297 | 3.160 |
Why?
| Genetic Predisposition to Disease | 65 | 2023 | 2099 | 3.000 |
Why?
| Genome-Wide Association Study | 44 | 2023 | 1197 | 2.750 |
Why?
| Genotype | 52 | 2023 | 1774 | 1.500 |
Why?
| Genome, Human | 17 | 2020 | 351 | 1.430 |
Why?
| Gene Frequency | 33 | 2022 | 481 | 1.380 |
Why?
| Genetic Variation | 25 | 2021 | 876 | 1.230 |
Why?
| Cardiovascular Diseases | 17 | 2022 | 1727 | 1.060 |
Why?
| Chromosomes, Human, Pair 17 | 11 | 2019 | 56 | 1.000 |
Why?
| Exome | 9 | 2016 | 200 | 0.930 |
Why?
| Haplotypes | 26 | 2016 | 453 | 0.830 |
Why?
| Alleles | 20 | 2018 | 791 | 0.820 |
Why?
| Chromosome Mapping | 25 | 2010 | 489 | 0.810 |
Why?
| Obesity | 15 | 2023 | 2513 | 0.810 |
Why?
| Body Mass Index | 17 | 2022 | 1958 | 0.810 |
Why?
| Hypertension | 7 | 2022 | 1059 | 0.800 |
Why?
| Genetic Loci | 10 | 2019 | 263 | 0.750 |
Why?
| Male | 134 | 2023 | 55579 | 0.740 |
Why?
| Models, Genetic | 14 | 2022 | 565 | 0.740 |
Why?
| Humans | 185 | 2023 | 114757 | 0.670 |
Why?
| Middle Aged | 77 | 2023 | 26757 | 0.670 |
Why?
| Pedigree | 24 | 2016 | 464 | 0.660 |
Why?
| Sickle Cell Trait | 4 | 2020 | 14 | 0.640 |
Why?
| Aged | 68 | 2023 | 19094 | 0.640 |
Why?
| Polymorphism, Genetic | 9 | 2009 | 612 | 0.640 |
Why?
| Genetic Association Studies | 9 | 2022 | 344 | 0.630 |
Why?
| Chromosomes, Human, Pair 8 | 5 | 2019 | 33 | 0.610 |
Why?
| Phenotype | 26 | 2021 | 2812 | 0.570 |
Why?
| Apolipoproteins E | 3 | 2015 | 80 | 0.550 |
Why?
| Adult | 72 | 2023 | 30548 | 0.530 |
Why?
| Female | 109 | 2023 | 59507 | 0.530 |
Why?
| Chromosomes, Human, Pair 6 | 2 | 2015 | 44 | 0.520 |
Why?
| Chromosomes, Human, Pair 11 | 11 | 2011 | 58 | 0.500 |
Why?
| Lipoprotein(a) | 1 | 2015 | 51 | 0.490 |
Why?
| Fibroblast Growth Factor 5 | 1 | 2015 | 2 | 0.490 |
Why?
| Plasma Membrane Calcium-Transporting ATPases | 1 | 2015 | 10 | 0.490 |
Why?
| Diabetes Mellitus, Type 2 | 10 | 2023 | 2097 | 0.490 |
Why?
| Transferrin | 1 | 2014 | 40 | 0.480 |
Why?
| Trinucleotide Repeats | 2 | 2008 | 24 | 0.470 |
Why?
| Ferritins | 1 | 2014 | 52 | 0.470 |
Why?
| Receptors, Androgen | 3 | 2017 | 131 | 0.470 |
Why?
| src-Family Kinases | 1 | 2015 | 88 | 0.460 |
Why?
| Quantitative Trait, Heritable | 9 | 2021 | 117 | 0.460 |
Why?
| Blood Pressure | 5 | 2020 | 1530 | 0.460 |
Why?
| Anemia, Iron-Deficiency | 1 | 2014 | 53 | 0.450 |
Why?
| Quantitative Trait Loci | 9 | 2022 | 307 | 0.450 |
Why?
| Family Health | 10 | 2017 | 194 | 0.440 |
Why?
| Fibrin Fibrinogen Degradation Products | 2 | 2017 | 80 | 0.430 |
Why?
| Iron | 1 | 2014 | 234 | 0.420 |
Why?
| Lod Score | 16 | 2011 | 65 | 0.420 |
Why?
| Ataxia Telangiectasia | 10 | 2004 | 17 | 0.410 |
Why?
| Microsatellite Repeats | 11 | 2012 | 136 | 0.400 |
Why?
| Receptors, Urokinase Plasminogen Activator | 2 | 2021 | 10 | 0.380 |
Why?
| Cohort Studies | 22 | 2020 | 4901 | 0.380 |
Why?
| Blood Coagulation | 2 | 2015 | 217 | 0.380 |
Why?
| Weight Gain | 5 | 2016 | 452 | 0.370 |
Why?
| Longitudinal Studies | 15 | 2022 | 2386 | 0.370 |
Why?
| Risk Factors | 25 | 2023 | 8627 | 0.360 |
Why?
| Control Groups | 1 | 2010 | 10 | 0.360 |
Why?
| Proteins | 7 | 2022 | 912 | 0.360 |
Why?
| Chromosomes, Human, Pair 10 | 1 | 2010 | 18 | 0.360 |
Why?
| X Chromosome | 2 | 2000 | 47 | 0.340 |
Why?
| Genes, BRCA1 | 3 | 2004 | 31 | 0.340 |
Why?
| Costs and Cost Analysis | 1 | 2010 | 195 | 0.340 |
Why?
| Germ-Line Mutation | 6 | 2020 | 130 | 0.330 |
Why?
| C-Reactive Protein | 5 | 2020 | 362 | 0.330 |
Why?
| Genetics, Population | 8 | 2021 | 188 | 0.330 |
Why?
| Leukemia, Lymphocytic, Chronic, B-Cell | 2 | 2020 | 56 | 0.330 |
Why?
| Atherosclerosis | 4 | 2022 | 342 | 0.330 |
Why?
| Chromosomes, Human, Pair 16 | 1 | 2009 | 30 | 0.320 |
Why?
| Malocclusion, Angle Class III | 1 | 2009 | 2 | 0.320 |
Why?
| Linkage Disequilibrium | 12 | 2017 | 245 | 0.320 |
Why?
| Young Adult | 23 | 2020 | 10463 | 0.300 |
Why?
| Tumor Suppressor Proteins | 5 | 2016 | 282 | 0.300 |
Why?
| Alzheimer Disease | 2 | 2023 | 443 | 0.300 |
Why?
| Veterans | 3 | 2023 | 1240 | 0.290 |
Why?
| Adiponectin | 5 | 2011 | 213 | 0.290 |
Why?
| Genetic Markers | 18 | 2017 | 321 | 0.290 |
Why?
| Case-Control Studies | 16 | 2023 | 3005 | 0.280 |
Why?
| Lipopolysaccharide Receptors | 2 | 2021 | 82 | 0.280 |
Why?
| Renal Insufficiency, Chronic | 2 | 2023 | 486 | 0.280 |
Why?
| Atrial Fibrillation | 2 | 2022 | 324 | 0.280 |
Why?
| Age of Onset | 6 | 2014 | 448 | 0.270 |
Why?
| Genetic Pleiotropy | 2 | 2016 | 29 | 0.270 |
Why?
| Kidney | 3 | 2023 | 1184 | 0.260 |
Why?
| Chromosomes, Human, Pair 15 | 1 | 2006 | 53 | 0.260 |
Why?
| Fibrinolysis | 1 | 2008 | 158 | 0.260 |
Why?
| Mutation, Missense | 7 | 2018 | 295 | 0.250 |
Why?
| Chromosomes, Human, Pair 20 | 4 | 2011 | 13 | 0.250 |
Why?
| Mendelian Randomization Analysis | 2 | 2023 | 43 | 0.250 |
Why?
| Apolipoprotein L1 | 2 | 2023 | 12 | 0.240 |
Why?
| United States | 24 | 2020 | 12176 | 0.240 |
Why?
| Genetic Techniques | 2 | 2004 | 58 | 0.240 |
Why?
| Blood Glucose | 6 | 2021 | 1821 | 0.240 |
Why?
| Inheritance Patterns | 1 | 2004 | 45 | 0.240 |
Why?
| Fasting | 4 | 2018 | 242 | 0.230 |
Why?
| Coronary Artery Disease | 4 | 2018 | 607 | 0.230 |
Why?
| Sequence Analysis, DNA | 7 | 2016 | 728 | 0.230 |
Why?
| Prospective Studies | 14 | 2021 | 6217 | 0.230 |
Why?
| Homocysteine | 2 | 2018 | 136 | 0.230 |
Why?
| Genetics | 1 | 2004 | 27 | 0.220 |
Why?
| Glomerulosclerosis, Focal Segmental | 1 | 2023 | 29 | 0.220 |
Why?
| Software | 4 | 2016 | 536 | 0.220 |
Why?
| Homeodomain Proteins | 3 | 2012 | 463 | 0.220 |
Why?
| Nuclear Proteins | 3 | 2014 | 592 | 0.220 |
Why?
| Mississippi | 3 | 2021 | 20 | 0.210 |
Why?
| Aged, 80 and over | 15 | 2020 | 6350 | 0.210 |
Why?
| Chromosomes, Human, Pair 1 | 5 | 2009 | 67 | 0.210 |
Why?
| Chronic Periodontitis | 2 | 2013 | 5 | 0.210 |
Why?
| Dementia, Vascular | 1 | 2022 | 16 | 0.210 |
Why?
| Adolescent | 28 | 2023 | 17808 | 0.210 |
Why?
| Diabetic Neuropathies | 1 | 2023 | 79 | 0.210 |
Why?
| DNA, Neoplasm | 5 | 2014 | 157 | 0.200 |
Why?
| Polymerase Chain Reaction | 8 | 2012 | 994 | 0.200 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2022 | 102 | 0.200 |
Why?
| Smoking | 2 | 2021 | 1384 | 0.190 |
Why?
| Aging, Premature | 1 | 2021 | 11 | 0.190 |
Why?
| Cell Transformation, Neoplastic | 2 | 2020 | 312 | 0.190 |
Why?
| Age Factors | 12 | 2021 | 2890 | 0.190 |
Why?
| Risk Assessment | 11 | 2021 | 2973 | 0.190 |
Why?
| Chromosomes, Human, X | 3 | 2015 | 60 | 0.190 |
Why?
| Methylenetetrahydrofolate Reductase (NADPH2) | 2 | 2012 | 34 | 0.190 |
Why?
| Nutrition Surveys | 4 | 2018 | 224 | 0.180 |
Why?
| Biomarkers | 7 | 2023 | 3416 | 0.180 |
Why?
| Linear Models | 4 | 2021 | 770 | 0.180 |
Why?
| Prognosis | 9 | 2021 | 3334 | 0.180 |
Why?
| Receptors, Adiponectin | 2 | 2011 | 15 | 0.180 |
Why?
| Carcinoma | 3 | 2010 | 198 | 0.180 |
Why?
| Exercise | 4 | 2016 | 1644 | 0.180 |
Why?
| Epigenomics | 1 | 2021 | 102 | 0.180 |
Why?
| Antigens, CD | 1 | 2022 | 443 | 0.170 |
Why?
| Whole Genome Sequencing | 1 | 2020 | 94 | 0.170 |
Why?
| DNA-Binding Proteins | 7 | 2020 | 1314 | 0.170 |
Why?
| Chemokine CXCL10 | 1 | 2020 | 34 | 0.170 |
Why?
| Factor VIII | 1 | 2020 | 54 | 0.170 |
Why?
| Adiposity | 2 | 2017 | 457 | 0.170 |
Why?
| Pediatric Obesity | 2 | 2017 | 489 | 0.170 |
Why?
| Statistics, Nonparametric | 4 | 2017 | 386 | 0.170 |
Why?
| Zinc Fingers | 2 | 2017 | 44 | 0.170 |
Why?
| Lymphadenopathy | 1 | 2019 | 8 | 0.170 |
Why?
| Genetic Testing | 4 | 2009 | 379 | 0.170 |
Why?
| Computer Simulation | 6 | 2021 | 878 | 0.170 |
Why?
| Repressor Proteins | 3 | 2014 | 367 | 0.170 |
Why?
| Renal Insufficiency | 1 | 2021 | 136 | 0.160 |
Why?
| Incidence | 7 | 2021 | 2312 | 0.160 |
Why?
| Mortality | 1 | 2021 | 288 | 0.160 |
Why?
| Child | 19 | 2022 | 18352 | 0.160 |
Why?
| Trabeculectomy | 1 | 2000 | 65 | 0.160 |
Why?
| Mutation | 8 | 2014 | 3350 | 0.160 |
Why?
| International Cooperation | 5 | 2011 | 172 | 0.160 |
Why?
| Neoplasm, Residual | 1 | 2019 | 104 | 0.160 |
Why?
| Lymphoma | 1 | 2020 | 177 | 0.160 |
Why?
| Epidemiologic Studies | 1 | 2019 | 57 | 0.160 |
Why?
| Cell Cycle Proteins | 4 | 2015 | 552 | 0.160 |
Why?
| Adolescent Health | 2 | 2015 | 37 | 0.160 |
Why?
| Fibrinogen | 2 | 2010 | 154 | 0.150 |
Why?
| Observational Studies as Topic | 1 | 2019 | 90 | 0.150 |
Why?
| Proteome | 1 | 2022 | 339 | 0.150 |
Why?
| alpha-Globins | 1 | 2018 | 11 | 0.150 |
Why?
| China | 2 | 2018 | 162 | 0.150 |
Why?
| Hemoglobin, Sickle | 1 | 2018 | 14 | 0.150 |
Why?
| Asthma | 5 | 2019 | 2032 | 0.150 |
Why?
| Health Surveys | 2 | 2018 | 443 | 0.150 |
Why?
| Brain Ischemia | 2 | 2015 | 299 | 0.150 |
Why?
| Gene Pool | 1 | 2017 | 5 | 0.150 |
Why?
| Antithrombin III | 1 | 2017 | 7 | 0.150 |
Why?
| Thromboplastin | 2 | 2017 | 71 | 0.150 |
Why?
| Receptors, LDL | 2 | 2014 | 38 | 0.150 |
Why?
| Glomerular Filtration Rate | 4 | 2023 | 604 | 0.150 |
Why?
| Factor VIIa | 1 | 2017 | 36 | 0.150 |
Why?
| Mitral Valve Prolapse | 1 | 2017 | 8 | 0.150 |
Why?
| Hemoglobins, Abnormal | 1 | 2017 | 10 | 0.150 |
Why?
| Fatty Liver | 1 | 2020 | 213 | 0.150 |
Why?
| Gene Expression | 1 | 2022 | 1420 | 0.150 |
Why?
| Leukocytes | 2 | 2016 | 277 | 0.140 |
Why?
| Blood Platelets | 2 | 2016 | 351 | 0.140 |
Why?
| Body Height | 2 | 2017 | 180 | 0.140 |
Why?
| Proportional Hazards Models | 6 | 2020 | 1080 | 0.140 |
Why?
| Gastrointestinal Microbiome | 1 | 2023 | 501 | 0.140 |
Why?
| Epigenesis, Genetic | 1 | 2021 | 521 | 0.140 |
Why?
| Glaucoma | 1 | 2000 | 202 | 0.140 |
Why?
| Interferon-gamma | 1 | 2020 | 722 | 0.140 |
Why?
| Erythropoiesis | 1 | 2016 | 34 | 0.130 |
Why?
| Antihypertensive Agents | 1 | 2020 | 429 | 0.130 |
Why?
| Schizophrenia | 5 | 2007 | 415 | 0.130 |
Why?
| Cadmium | 1 | 2016 | 58 | 0.130 |
Why?
| Algorithms | 3 | 2021 | 1468 | 0.130 |
Why?
| Immune System Diseases | 1 | 2016 | 32 | 0.130 |
Why?
| Cross-Sectional Studies | 8 | 2021 | 4409 | 0.130 |
Why?
| Insulin-Like Growth Factor I | 2 | 2009 | 286 | 0.130 |
Why?
| Microbiota | 1 | 2023 | 648 | 0.130 |
Why?
| Chromosomes, Human, Y | 1 | 2015 | 13 | 0.130 |
Why?
| Factor XII | 1 | 2015 | 5 | 0.130 |
Why?
| Disease | 1 | 2016 | 85 | 0.130 |
Why?
| Immunotherapy | 1 | 2019 | 475 | 0.130 |
Why?
| Receptors, Neurokinin-3 | 1 | 2015 | 6 | 0.130 |
Why?
| Cholesterol, LDL | 2 | 2014 | 307 | 0.130 |
Why?
| Oligonucleotide Array Sequence Analysis | 2 | 2015 | 743 | 0.130 |
Why?
| Energy Metabolism | 2 | 2017 | 729 | 0.130 |
Why?
| Interleukin-2 Receptor alpha Subunit | 1 | 2015 | 66 | 0.130 |
Why?
| Laminin | 1 | 2015 | 69 | 0.120 |
Why?
| Motor Activity | 2 | 2013 | 640 | 0.120 |
Why?
| Menarche | 1 | 2015 | 49 | 0.120 |
Why?
| Calcium-Binding Proteins | 2 | 2013 | 207 | 0.120 |
Why?
| Membrane Proteins | 3 | 2016 | 1022 | 0.120 |
Why?
| Gene-Environment Interaction | 1 | 2016 | 184 | 0.120 |
Why?
| Energy Intake | 1 | 2017 | 427 | 0.120 |
Why?
| Chromosomes, Human, Pair 5 | 2 | 2012 | 24 | 0.120 |
Why?
| Chromosomes, Human, Pair 12 | 2 | 2019 | 20 | 0.120 |
Why?
| Immunoglobulins | 1 | 2015 | 143 | 0.120 |
Why?
| Mutation Rate | 1 | 2015 | 26 | 0.120 |
Why?
| Apolipoproteins A | 1 | 2014 | 18 | 0.120 |
Why?
| Anemia, Sickle Cell | 1 | 2018 | 216 | 0.120 |
Why?
| Epistasis, Genetic | 1 | 2015 | 67 | 0.120 |
Why?
| Insulin Resistance | 2 | 2021 | 1072 | 0.120 |
Why?
| Thrombin | 1 | 2015 | 139 | 0.120 |
Why?
| Africa | 2 | 2020 | 95 | 0.120 |
Why?
| Residence Characteristics | 1 | 2016 | 275 | 0.120 |
Why?
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2019 | 1361 | 0.120 |
Why?
| DNA, Mitochondrial | 1 | 2015 | 182 | 0.120 |
Why?
| CD36 Antigens | 1 | 2014 | 37 | 0.110 |
Why?
| AMP-Activated Protein Kinases | 1 | 2015 | 175 | 0.110 |
Why?
| RNA, Long Noncoding | 1 | 2016 | 154 | 0.110 |
Why?
| CARD Signaling Adaptor Proteins | 1 | 2013 | 17 | 0.110 |
Why?
| Chromosomes, Human, Pair 2 | 1 | 2013 | 27 | 0.110 |
Why?
| Penetrance | 2 | 2015 | 27 | 0.110 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2016 | 368 | 0.110 |
Why?
| Diabetes, Gestational | 1 | 2017 | 281 | 0.110 |
Why?
| Philippines | 5 | 2011 | 50 | 0.110 |
Why?
| Time Factors | 6 | 2021 | 6124 | 0.110 |
Why?
| Blood Cells | 1 | 2012 | 38 | 0.100 |
Why?
| Periodontium | 1 | 2012 | 2 | 0.100 |
Why?
| Meta-Analysis as Topic | 4 | 2014 | 161 | 0.100 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2019 | 536 | 0.100 |
Why?
| Autoantigens | 1 | 2015 | 396 | 0.100 |
Why?
| Interleukin 1 Receptor Antagonist Protein | 1 | 2013 | 253 | 0.100 |
Why?
| Promoter Regions, Genetic | 3 | 2006 | 1133 | 0.100 |
Why?
| RNA-Binding Proteins | 1 | 2015 | 344 | 0.100 |
Why?
| Interleukin-18 | 1 | 2013 | 219 | 0.100 |
Why?
| Glutathione Transferase | 1 | 2012 | 94 | 0.100 |
Why?
| Arsenic | 1 | 2012 | 37 | 0.100 |
Why?
| Prenatal Exposure Delayed Effects | 1 | 2017 | 452 | 0.100 |
Why?
| Methyltransferases | 1 | 2012 | 61 | 0.100 |
Why?
| Chromosomes, Human, Pair 4 | 1 | 2011 | 27 | 0.100 |
Why?
| Logistic Models | 3 | 2012 | 1843 | 0.100 |
Why?
| Factor VII | 1 | 2011 | 26 | 0.100 |
Why?
| Erythrocytes | 1 | 2016 | 591 | 0.090 |
Why?
| Metagenome | 1 | 2012 | 122 | 0.090 |
Why?
| Sample Size | 3 | 2021 | 114 | 0.090 |
Why?
| Chromosomes, Human, Pair 22 | 2 | 2010 | 38 | 0.090 |
Why?
| Cystic Fibrosis | 2 | 2011 | 955 | 0.090 |
Why?
| Indians, North American | 1 | 2016 | 570 | 0.090 |
Why?
| Homozygote | 3 | 2012 | 187 | 0.090 |
Why?
| Kininogen, Low-Molecular-Weight | 1 | 2010 | 2 | 0.090 |
Why?
| Kininogens | 1 | 2010 | 4 | 0.090 |
Why?
| Kininogen, High-Molecular-Weight | 1 | 2010 | 3 | 0.090 |
Why?
| Mathematical Computing | 1 | 2010 | 12 | 0.090 |
Why?
| Family | 4 | 2006 | 591 | 0.090 |
Why?
| TCF Transcription Factors | 1 | 2010 | 20 | 0.090 |
Why?
| Nandrolone | 1 | 2010 | 2 | 0.090 |
Why?
| Population | 1 | 2010 | 28 | 0.090 |
Why?
| Malawi | 1 | 2010 | 48 | 0.090 |
Why?
| Carbamoyl-Phosphate Synthase (Ammonia) | 1 | 2010 | 6 | 0.090 |
Why?
| Ethinyl Estradiol | 1 | 2010 | 17 | 0.090 |
Why?
| Molecular Epidemiology | 2 | 2022 | 62 | 0.090 |
Why?
| Contraceptives, Oral, Hormonal | 1 | 2010 | 23 | 0.090 |
Why?
| Carbohydrate Metabolism | 1 | 2010 | 49 | 0.090 |
Why?
| Heart Failure | 1 | 2022 | 1952 | 0.090 |
Why?
| RNA Helicases | 1 | 2009 | 20 | 0.080 |
Why?
| Myocardial Infarction | 2 | 2014 | 927 | 0.080 |
Why?
| Alpha-Ketoglutarate-Dependent Dioxygenase FTO | 3 | 2016 | 22 | 0.080 |
Why?
| Multifactorial Inheritance | 2 | 2023 | 125 | 0.080 |
Why?
| Heterozygote | 3 | 2016 | 251 | 0.080 |
Why?
| Urinary Bladder Neoplasms | 1 | 2012 | 196 | 0.080 |
Why?
| Peptidyl-Dipeptidase A | 2 | 2009 | 51 | 0.080 |
Why?
| WW Domain-Containing Oxidoreductase | 1 | 2009 | 1 | 0.080 |
Why?
| Cadherins | 1 | 2010 | 176 | 0.080 |
Why?
| Maxilla | 1 | 2009 | 29 | 0.080 |
Why?
| Cephalometry | 1 | 2009 | 28 | 0.080 |
Why?
| Chromosomes, Human, Pair 3 | 1 | 2009 | 49 | 0.080 |
Why?
| Stroke | 2 | 2015 | 1019 | 0.080 |
Why?
| Genes, Recessive | 4 | 2004 | 73 | 0.080 |
Why?
| Glucose Intolerance | 1 | 2010 | 138 | 0.080 |
Why?
| Genes, Homeobox | 1 | 2009 | 50 | 0.080 |
Why?
| Poly(ADP-ribose) Polymerases | 1 | 2009 | 88 | 0.080 |
Why?
| Collagen Type II | 1 | 2009 | 48 | 0.080 |
Why?
| Environmental Exposure | 1 | 2012 | 374 | 0.080 |
Why?
| Prostate-Specific Antigen | 2 | 2007 | 153 | 0.080 |
Why?
| Psoriasis | 2 | 2002 | 74 | 0.080 |
Why?
| Oxidoreductases | 1 | 2009 | 92 | 0.080 |
Why?
| Adolescent Behavior | 1 | 2013 | 489 | 0.080 |
Why?
| alpha 1-Antitrypsin | 1 | 2009 | 100 | 0.080 |
Why?
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 1 | 2008 | 9 | 0.080 |
Why?
| Insulin-Like Growth Factor Binding Proteins | 1 | 2008 | 24 | 0.080 |
Why?
| Urokinase-Type Plasminogen Activator | 1 | 2008 | 28 | 0.070 |
Why?
| National Heart, Lung, and Blood Institute (U.S.) | 2 | 2020 | 93 | 0.070 |
Why?
| Interleukin-6 | 2 | 2009 | 675 | 0.070 |
Why?
| Breast Neoplasms | 3 | 2004 | 1868 | 0.070 |
Why?
| Plasminogen Activator Inhibitor 1 | 1 | 2008 | 83 | 0.070 |
Why?
| Cytochrome P-450 Enzyme System | 1 | 2008 | 108 | 0.070 |
Why?
| HLA-DR2 Antigen | 1 | 2007 | 8 | 0.070 |
Why?
| Prediabetic State | 1 | 2010 | 220 | 0.070 |
Why?
| Genes, Dominant | 2 | 2004 | 94 | 0.070 |
Why?
| Germany | 3 | 2020 | 84 | 0.070 |
Why?
| BRCA1 Protein | 1 | 2007 | 56 | 0.070 |
Why?
| Europe | 1 | 2008 | 336 | 0.070 |
Why?
| High-Throughput Nucleotide Sequencing | 3 | 2016 | 440 | 0.070 |
Why?
| DNA Methylation | 2 | 2021 | 496 | 0.070 |
Why?
| HLA-DR3 Antigen | 1 | 2007 | 79 | 0.070 |
Why?
| Neural Cell Adhesion Molecules | 1 | 2006 | 24 | 0.070 |
Why?
| Liver Diseases | 1 | 2009 | 254 | 0.070 |
Why?
| Sex Factors | 5 | 2017 | 1717 | 0.070 |
Why?
| Prostatic Intraepithelial Neoplasia | 1 | 2006 | 12 | 0.070 |
Why?
| Infant | 5 | 2010 | 7935 | 0.070 |
Why?
| 3',5'-Cyclic-AMP Phosphodiesterases | 1 | 2006 | 12 | 0.070 |
Why?
| Transcription Factors | 3 | 2012 | 1528 | 0.070 |
Why?
| Mixed Function Oxygenases | 1 | 2006 | 36 | 0.070 |
Why?
| Follow-Up Studies | 4 | 2014 | 4420 | 0.070 |
Why?
| Genomics | 2 | 2007 | 639 | 0.070 |
Why?
| Genes, Lethal | 1 | 2005 | 26 | 0.060 |
Why?
| Pimozide | 2 | 1976 | 4 | 0.060 |
Why?
| Genomic Imprinting | 1 | 2005 | 32 | 0.060 |
Why?
| National Longitudinal Study of Adolescent Health | 2 | 2016 | 7 | 0.060 |
Why?
| Kaplan-Meier Estimate | 2 | 2019 | 815 | 0.060 |
Why?
| Warfarin | 1 | 2006 | 135 | 0.060 |
Why?
| Chromosomes | 1 | 2005 | 87 | 0.060 |
Why?
| Immunoglobulin E | 2 | 2003 | 316 | 0.060 |
Why?
| Multigene Family | 1 | 2005 | 193 | 0.060 |
Why?
| Serum | 1 | 2005 | 57 | 0.060 |
Why?
| Lung Diseases | 1 | 2011 | 696 | 0.060 |
Why?
| Proto-Oncogene Proteins c-akt | 1 | 2007 | 399 | 0.060 |
Why?
| Survival Analysis | 2 | 2020 | 1218 | 0.060 |
Why?
| Platelet Count | 2 | 2016 | 81 | 0.060 |
Why?
| Lupus Erythematosus, Systemic | 1 | 2007 | 221 | 0.060 |
Why?
| Fertility | 1 | 2005 | 130 | 0.060 |
Why?
| Hematocrit | 2 | 2016 | 85 | 0.060 |
Why?
| Neoplasm Invasiveness | 1 | 2006 | 445 | 0.060 |
Why?
| Receptor, Melanocortin, Type 4 | 2 | 2016 | 11 | 0.060 |
Why?
| Siblings | 3 | 2010 | 222 | 0.060 |
Why?
| Michigan | 3 | 2012 | 96 | 0.060 |
Why?
| Physical Fitness | 1 | 2005 | 179 | 0.060 |
Why?
| Apolipoproteins | 1 | 2023 | 36 | 0.060 |
Why?
| Insulin | 4 | 2021 | 2079 | 0.060 |
Why?
| Meiosis | 1 | 2004 | 59 | 0.060 |
Why?
| Syndrome | 3 | 2017 | 334 | 0.060 |
Why?
| Intermediate Filaments | 1 | 2023 | 46 | 0.050 |
Why?
| Societies, Medical | 1 | 2007 | 663 | 0.050 |
Why?
| Hypersensitivity, Immediate | 1 | 2003 | 46 | 0.050 |
Why?
| Neurofilament Proteins | 1 | 2023 | 34 | 0.050 |
Why?
| Pilot Projects | 2 | 2022 | 1370 | 0.050 |
Why?
| Asialoglycoprotein Receptor | 1 | 2022 | 4 | 0.050 |
Why?
| Disease Progression | 2 | 2020 | 2387 | 0.050 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2003 | 119 | 0.050 |
Why?
| Tropomyosin | 1 | 2002 | 12 | 0.050 |
Why?
| Inflammation | 2 | 2013 | 2481 | 0.050 |
Why?
| Cognition Disorders | 1 | 2007 | 477 | 0.050 |
Why?
| Endoribonucleases | 1 | 2003 | 62 | 0.050 |
Why?
| Osteoarthritis, Knee | 1 | 2005 | 213 | 0.050 |
Why?
| Antigens, Differentiation, Myelomonocytic | 1 | 2022 | 54 | 0.050 |
Why?
| Hemoglobins | 2 | 2016 | 314 | 0.050 |
Why?
| Genome | 1 | 2004 | 272 | 0.050 |
Why?
| Receptors, Immunologic | 1 | 2003 | 201 | 0.050 |
Why?
| Risk | 3 | 2010 | 815 | 0.050 |
Why?
| Anticoagulants | 1 | 2006 | 547 | 0.050 |
Why?
| Adenocarcinoma | 1 | 2008 | 801 | 0.050 |
Why?
| Biomarkers, Tumor | 2 | 2006 | 1053 | 0.050 |
Why?
| Data Interpretation, Statistical | 2 | 2015 | 322 | 0.050 |
Why?
| Causality | 1 | 2021 | 104 | 0.050 |
Why?
| CpG Islands | 1 | 2021 | 117 | 0.050 |
Why?
| Drosophila Proteins | 1 | 2002 | 163 | 0.050 |
Why?
| alpha Karyopherins | 1 | 2020 | 13 | 0.050 |
Why?
| Platelet Factor 4 | 1 | 1980 | 21 | 0.050 |
Why?
| HLA Antigens | 1 | 2002 | 224 | 0.050 |
Why?
| Kidney Function Tests | 1 | 2021 | 140 | 0.050 |
Why?
| Tripartite Motif Proteins | 1 | 2020 | 30 | 0.050 |
Why?
| Disease Susceptibility | 4 | 2009 | 316 | 0.050 |
Why?
| Dioxygenases | 1 | 2020 | 25 | 0.040 |
Why?
| Mitogens | 1 | 1980 | 58 | 0.040 |
Why?
| Blood Coagulation Factors | 1 | 1980 | 44 | 0.040 |
Why?
| Growth Substances | 1 | 1980 | 136 | 0.040 |
Why?
| Codon, Nonsense | 2 | 2015 | 37 | 0.040 |
Why?
| Cell Adhesion Molecules | 2 | 2017 | 168 | 0.040 |
Why?
| Cell Self Renewal | 1 | 2020 | 49 | 0.040 |
Why?
| Body Weight | 3 | 2010 | 869 | 0.040 |
Why?
| Diabetic Nephropathies | 1 | 2003 | 234 | 0.040 |
Why?
| Tobacco Smoke Pollution | 1 | 2003 | 217 | 0.040 |
Why?
| Africa, Western | 1 | 2020 | 16 | 0.040 |
Why?
| DNA Mutational Analysis | 2 | 2016 | 372 | 0.040 |
Why?
| Models, Statistical | 1 | 2004 | 604 | 0.040 |
Why?
| Carotid Intima-Media Thickness | 1 | 2020 | 65 | 0.040 |
Why?
| von Willebrand Factor | 1 | 2020 | 56 | 0.040 |
Why?
| Albuminuria | 1 | 2020 | 164 | 0.040 |
Why?
| Infant, Newborn | 3 | 2017 | 5035 | 0.040 |
Why?
| Bayes Theorem | 2 | 2016 | 331 | 0.040 |
Why?
| Exons | 3 | 2006 | 303 | 0.040 |
Why?
| Cognition | 1 | 2006 | 989 | 0.040 |
Why?
| Calcinosis | 1 | 2002 | 242 | 0.040 |
Why?
| Autoantibodies | 1 | 2007 | 1350 | 0.040 |
Why?
| Idarubicin | 1 | 2019 | 3 | 0.040 |
Why?
| Neoplasm Grading | 1 | 2020 | 242 | 0.040 |
Why?
| Brain | 3 | 2007 | 2374 | 0.040 |
Why?
| Abdomen | 1 | 2019 | 100 | 0.040 |
Why?
| Creatinine | 1 | 2020 | 424 | 0.040 |
Why?
| Pregnancy | 3 | 2021 | 5525 | 0.040 |
Why?
| Induction Chemotherapy | 1 | 2019 | 56 | 0.040 |
Why?
| Treatment Outcome | 3 | 2019 | 9089 | 0.040 |
Why?
| Etoposide | 1 | 2019 | 148 | 0.040 |
Why?
| Chromosome Breakage | 1 | 1998 | 21 | 0.040 |
Why?
| alpha-Thalassemia | 1 | 2018 | 4 | 0.040 |
Why?
| Erythrocytes, Abnormal | 1 | 2018 | 13 | 0.040 |
Why?
| Research Design | 1 | 2004 | 931 | 0.040 |
Why?
| Prostate | 2 | 2012 | 156 | 0.040 |
Why?
| Kidney Failure, Chronic | 1 | 2003 | 487 | 0.040 |
Why?
| Endothelial Protein C Receptor | 1 | 2017 | 5 | 0.040 |
Why?
| Intracellular Signaling Peptides and Proteins | 1 | 2020 | 386 | 0.040 |
Why?
| Disease-Free Survival | 1 | 2019 | 623 | 0.040 |
Why?
| Cytokines | 1 | 2005 | 1843 | 0.040 |
Why?
| Amino Acid Substitution | 2 | 2012 | 262 | 0.040 |
Why?
| Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 1 | 2017 | 3 | 0.040 |
Why?
| Azacitidine | 1 | 2019 | 129 | 0.040 |
Why?
| Intraocular Pressure | 1 | 2000 | 276 | 0.040 |
Why?
| Homeostasis | 1 | 2021 | 575 | 0.040 |
Why?
| Hematopoietic Stem Cells | 1 | 2020 | 345 | 0.040 |
Why?
| DNA | 2 | 2022 | 1351 | 0.040 |
Why?
| ADAMTS Proteins | 1 | 2017 | 5 | 0.040 |
Why?
| Interleukin-11 Receptor alpha Subunit | 1 | 2017 | 3 | 0.040 |
Why?
| Procollagen N-Endopeptidase | 1 | 2017 | 8 | 0.040 |
Why?
| NADPH Oxidase 4 | 1 | 2017 | 8 | 0.040 |
Why?
| DNA Copy Number Variations | 1 | 2018 | 158 | 0.040 |
Why?
| Somatomedins | 1 | 2017 | 28 | 0.040 |
Why?
| Pregnancy-Associated Plasma Protein-A | 1 | 2017 | 14 | 0.040 |
Why?
| Precision Medicine | 1 | 2020 | 338 | 0.040 |
Why?
| Lymph Nodes | 1 | 2019 | 423 | 0.030 |
Why?
| Proto-Oncogene Proteins | 1 | 2020 | 610 | 0.030 |
Why?
| Mitochondrial Membrane Transport Proteins | 1 | 2016 | 30 | 0.030 |
Why?
| Body Burden | 1 | 2016 | 5 | 0.030 |
Why?
| Interferon Regulatory Factors | 1 | 2017 | 29 | 0.030 |
Why?
| Autopsy | 1 | 1997 | 84 | 0.030 |
Why?
| Statistics as Topic | 1 | 2017 | 294 | 0.030 |
Why?
| Muridae | 1 | 1996 | 5 | 0.030 |
Why?
| Mean Platelet Volume | 1 | 2016 | 3 | 0.030 |
Why?
| Allelic Imbalance | 1 | 2016 | 7 | 0.030 |
Why?
| Transcription Factor AP-2 | 1 | 2016 | 81 | 0.030 |
Why?
| Drosophila | 1 | 2017 | 133 | 0.030 |
Why?
| NADPH Oxidases | 1 | 2017 | 120 | 0.030 |
Why?
| Geographic Information Systems | 1 | 2016 | 37 | 0.030 |
Why?
| Glycosaminoglycans | 1 | 2017 | 79 | 0.030 |
Why?
| Parents | 1 | 2004 | 1190 | 0.030 |
Why?
| Erythrocyte Indices | 1 | 2016 | 28 | 0.030 |
Why?
| Transportation | 1 | 2016 | 44 | 0.030 |
Why?
| Neoplasm Staging | 1 | 2020 | 1176 | 0.030 |
Why?
| Blood Cell Count | 1 | 2016 | 52 | 0.030 |
Why?
| Biopsy | 1 | 2020 | 1040 | 0.030 |
Why?
| Proteoglycans | 1 | 2017 | 107 | 0.030 |
Why?
| Proteolysis | 1 | 2017 | 143 | 0.030 |
Why?
| Glucose | 1 | 2021 | 897 | 0.030 |
Why?
| Adipose Tissue | 1 | 2020 | 539 | 0.030 |
Why?
| Homicide | 1 | 1997 | 53 | 0.030 |
Why?
| Diet | 1 | 2023 | 1080 | 0.030 |
Why?
| Gene Expression Regulation | 2 | 2021 | 2321 | 0.030 |
Why?
| Quality Control | 1 | 2016 | 144 | 0.030 |
Why?
| Electrocardiography | 1 | 2019 | 562 | 0.030 |
Why?
| Prevalence | 2 | 2013 | 2249 | 0.030 |
Why?
| Area Under Curve | 1 | 2016 | 275 | 0.030 |
Why?
| Chromosomes, Human | 2 | 2009 | 39 | 0.030 |
Why?
| Hedgehog Proteins | 1 | 2017 | 173 | 0.030 |
Why?
| Genes, X-Linked | 1 | 2015 | 16 | 0.030 |
Why?
| Normal Distribution | 1 | 2015 | 19 | 0.030 |
Why?
| Circadian Rhythm | 1 | 2018 | 355 | 0.030 |
Why?
| Glucose-6-Phosphatase | 1 | 2015 | 31 | 0.030 |
Why?
| Apolipoprotein A-V | 1 | 2014 | 3 | 0.030 |
Why?
| Glycoproteins | 1 | 2017 | 304 | 0.030 |
Why?
| ROC Curve | 1 | 2016 | 445 | 0.030 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2017 | 350 | 0.030 |
Why?
| Child, Preschool | 4 | 2009 | 9079 | 0.030 |
Why?
| Hypogonadism | 1 | 2015 | 75 | 0.030 |
Why?
| Amides | 1 | 2015 | 87 | 0.030 |
Why?
| Population Surveillance | 1 | 2018 | 392 | 0.030 |
Why?
| Cell Adhesion Molecules, Neuronal | 1 | 1995 | 35 | 0.030 |
Why?
| Birth Weight | 1 | 2017 | 440 | 0.030 |
Why?
| Echocardiography | 1 | 2017 | 554 | 0.030 |
Why?
| Environment | 1 | 2016 | 336 | 0.030 |
Why?
| Age Distribution | 1 | 2015 | 339 | 0.030 |
Why?
| Sex Distribution | 1 | 2015 | 335 | 0.030 |
Why?
| Mothers | 2 | 2010 | 651 | 0.030 |
Why?
| Molecular Sequence Data | 3 | 2012 | 2791 | 0.030 |
Why?
| Glucagon-Like Peptide-1 Receptor | 1 | 2015 | 71 | 0.030 |
Why?
| Genetic Code | 1 | 2014 | 20 | 0.030 |
Why?
| Proprotein Convertases | 1 | 2014 | 14 | 0.030 |
Why?
| Amino Acid Sequence | 2 | 2012 | 1988 | 0.030 |
Why?
| Lipase | 1 | 2014 | 57 | 0.030 |
Why?
| Proprotein Convertase 9 | 1 | 2014 | 61 | 0.030 |
Why?
| RNA Interference | 1 | 2015 | 437 | 0.030 |
Why?
| Serine Endopeptidases | 1 | 2014 | 102 | 0.030 |
Why?
| Video Games | 1 | 2013 | 21 | 0.030 |
Why?
| Receptors, Aryl Hydrocarbon | 1 | 1993 | 39 | 0.030 |
Why?
| Ambulatory Care | 2 | 1976 | 479 | 0.030 |
Why?
| Hexosyltransferases | 1 | 2012 | 5 | 0.030 |
Why?
| Television | 1 | 2013 | 71 | 0.030 |
Why?
| International Agencies | 1 | 2012 | 30 | 0.030 |
Why?
| Confidence Intervals | 2 | 2003 | 309 | 0.030 |
Why?
| Prevotella nigrescens | 1 | 2012 | 1 | 0.030 |
Why?
| Vesicle-Associated Membrane Protein 3 | 1 | 2012 | 2 | 0.030 |
Why?
| Prevotella intermedia | 1 | 2012 | 2 | 0.030 |
Why?
| Campylobacter rectus | 1 | 2012 | 2 | 0.030 |
Why?
| Treponema denticola | 1 | 2012 | 2 | 0.030 |
Why?
| Fusobacterium nucleatum | 1 | 2012 | 3 | 0.030 |
Why?
| Triglycerides | 1 | 2014 | 470 | 0.030 |
Why?
| Fatty Acids | 1 | 2015 | 382 | 0.030 |
Why?
| Bacteroides | 1 | 2012 | 16 | 0.030 |
Why?
| Neuropsychological Tests | 2 | 2007 | 926 | 0.030 |
Why?
| Porphyromonas gingivalis | 1 | 2012 | 17 | 0.030 |
Why?
| Aggregatibacter actinomycetemcomitans | 1 | 2012 | 19 | 0.030 |
Why?
| Core Binding Factor Alpha 1 Subunit | 1 | 2012 | 41 | 0.030 |
Why?
| Potassium Channels, Tandem Pore Domain | 1 | 2012 | 12 | 0.030 |
Why?
| Hematologic Diseases | 1 | 2012 | 57 | 0.030 |
Why?
| F-Box Proteins | 1 | 2012 | 20 | 0.030 |
Why?
| Bacterial Load | 1 | 2012 | 58 | 0.030 |
Why?
| Liver | 1 | 2020 | 1631 | 0.030 |
Why?
| Nuclear Family | 2 | 2003 | 49 | 0.030 |
Why?
| Dyslipidemias | 1 | 2014 | 154 | 0.030 |
Why?
| Fetal Diseases | 1 | 1993 | 147 | 0.030 |
Why?
| Interleukin-33 | 1 | 2012 | 38 | 0.030 |
Why?
| Principal Component Analysis | 1 | 2012 | 176 | 0.020 |
Why?
| Sequence Homology, Amino Acid | 1 | 2012 | 353 | 0.020 |
Why?
| Nucleic Acid Hybridization | 1 | 2012 | 187 | 0.020 |
Why?
| Islets of Langerhans | 1 | 2018 | 728 | 0.020 |
Why?
| Prenatal Diagnosis | 1 | 1993 | 167 | 0.020 |
Why?
| Crosses, Genetic | 2 | 2005 | 140 | 0.020 |
Why?
| DNA Primers | 1 | 2012 | 514 | 0.020 |
Why?
| Signal Transduction | 2 | 2015 | 4522 | 0.020 |
Why?
| Drinking Water | 1 | 2012 | 64 | 0.020 |
Why?
| Ubiquitin-Protein Ligases | 1 | 2012 | 139 | 0.020 |
Why?
| Finland | 2 | 2001 | 69 | 0.020 |
Why?
| Southeastern United States | 1 | 2010 | 30 | 0.020 |
Why?
| DNA, Bacterial | 1 | 2012 | 310 | 0.020 |
Why?
| Recombination, Genetic | 3 | 1998 | 176 | 0.020 |
Why?
| Cooperative Behavior | 1 | 2013 | 381 | 0.020 |
Why?
| Interleukins | 1 | 2012 | 236 | 0.020 |
Why?
| Transcription Factor 7-Like 2 Protein | 1 | 2010 | 24 | 0.020 |
Why?
| Hypertriglyceridemia | 1 | 2010 | 34 | 0.020 |
Why?
| Waist Circumference | 1 | 2010 | 122 | 0.020 |
Why?
| Menstruation | 1 | 2010 | 35 | 0.020 |
Why?
| Fanconi Anemia Complementation Group Proteins | 1 | 2009 | 8 | 0.020 |
Why?
| Animals | 6 | 2017 | 31762 | 0.020 |
Why?
| Immunohistochemistry | 1 | 2014 | 1635 | 0.020 |
Why?
| Glutathione S-Transferase pi | 1 | 2009 | 8 | 0.020 |
Why?
| Trans-Activators | 1 | 2012 | 368 | 0.020 |
Why?
| Mannose-Binding Lectin | 1 | 2009 | 21 | 0.020 |
Why?
| Inflammation Mediators | 1 | 2012 | 476 | 0.020 |
Why?
| C-Peptide | 1 | 2010 | 138 | 0.020 |
Why?
| Body Composition | 1 | 2013 | 592 | 0.020 |
Why?
| Twins | 1 | 2010 | 240 | 0.020 |
Why?
| Hypertension, Portal | 1 | 2009 | 61 | 0.020 |
Why?
| Multivariate Analysis | 1 | 2012 | 1435 | 0.020 |
Why?
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2009 | 40 | 0.020 |
Why?
| Glucose Tolerance Test | 1 | 2010 | 343 | 0.020 |
Why?
| Transforming Growth Factor beta1 | 1 | 2009 | 153 | 0.020 |
Why?
| Educational Status | 1 | 2010 | 412 | 0.020 |
Why?
| Interviews as Topic | 1 | 2011 | 582 | 0.020 |
Why?
| Fanconi Anemia Complementation Group N Protein | 1 | 2008 | 5 | 0.020 |
Why?
| Puberty | 1 | 2009 | 135 | 0.020 |
Why?
| Nutritional Status | 1 | 2010 | 286 | 0.020 |
Why?
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2008 | 38 | 0.020 |
Why?
| Intracranial Arteriosclerosis | 2 | 2006 | 8 | 0.020 |
Why?
| Fathers | 1 | 2008 | 45 | 0.020 |
Why?
| Longevity | 1 | 2009 | 137 | 0.020 |
Why?
| Liver Cirrhosis | 1 | 2009 | 228 | 0.020 |
Why?
| Monte Carlo Method | 2 | 2002 | 137 | 0.020 |
Why?
| Isoenzymes | 1 | 2008 | 285 | 0.020 |
Why?
| Mice, Inbred C57BL | 1 | 1996 | 4710 | 0.020 |
Why?
| Tunica Intima | 1 | 2006 | 78 | 0.020 |
Why?
| Genetic Heterogeneity | 1 | 2006 | 49 | 0.020 |
Why?
| Vitamin K Epoxide Reductases | 1 | 2006 | 11 | 0.020 |
Why?
| Cytochrome P-450 CYP2C9 | 1 | 2006 | 17 | 0.020 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 4 | 1 | 2006 | 6 | 0.020 |
Why?
| Cyclic Nucleotide Phosphodiesterases, Type 3 | 1 | 2006 | 10 | 0.020 |
Why?
| International Normalized Ratio | 1 | 2006 | 45 | 0.020 |
Why?
| Sweden | 1 | 2006 | 65 | 0.020 |
Why?
| Aryl Hydrocarbon Hydroxylases | 1 | 2006 | 41 | 0.020 |
Why?
| Embolism | 1 | 2006 | 43 | 0.020 |
Why?
| Weight Lifting | 1 | 2005 | 29 | 0.020 |
Why?
| Arterial Occlusive Diseases | 1 | 2006 | 73 | 0.020 |
Why?
| Carotid Arteries | 1 | 2006 | 180 | 0.020 |
Why?
| DNA Probes | 2 | 1997 | 59 | 0.020 |
Why?
| Electrophoretic Mobility Shift Assay | 1 | 2005 | 73 | 0.020 |
Why?
| Mice, Inbred Strains | 1 | 2005 | 396 | 0.020 |
Why?
| DNA Replication | 1 | 2006 | 205 | 0.010 |
Why?
| Statistical Distributions | 1 | 2004 | 7 | 0.010 |
Why?
| Adult Children | 1 | 2003 | 21 | 0.010 |
Why?
| Analysis of Variance | 1 | 2006 | 1226 | 0.010 |
Why?
| Mice | 4 | 2005 | 14916 | 0.010 |
Why?
| Likelihood Functions | 1 | 2003 | 126 | 0.010 |
Why?
| Scavenger Receptors, Class A | 1 | 2003 | 9 | 0.010 |
Why?
| Receptors, Scavenger | 1 | 2003 | 16 | 0.010 |
Why?
| Consanguinity | 2 | 1994 | 47 | 0.010 |
Why?
| Radiography | 1 | 2006 | 811 | 0.010 |
Why?
| Systole | 1 | 2003 | 171 | 0.010 |
Why?
| Minisatellite Repeats | 1 | 2003 | 38 | 0.010 |
Why?
| Skin Tests | 1 | 2003 | 122 | 0.010 |
Why?
| X-ray Repair Cross Complementing Protein 1 | 1 | 2003 | 14 | 0.010 |
Why?
| Polymorphism, Restriction Fragment Length | 1 | 2003 | 65 | 0.010 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2004 | 472 | 0.010 |
Why?
| 3' Untranslated Regions | 1 | 2003 | 129 | 0.010 |
Why?
| Heart Diseases | 1 | 2006 | 330 | 0.010 |
Why?
| Reproducibility of Results | 1 | 2010 | 2763 | 0.010 |
Why?
| Cell Line | 2 | 2002 | 2639 | 0.010 |
Why?
| RNA, Neoplasm | 1 | 2002 | 80 | 0.010 |
Why?
| Transduction, Genetic | 1 | 2002 | 113 | 0.010 |
Why?
| Depressive Disorder, Major | 2 | 1976 | 299 | 0.010 |
Why?
| Phylogeny | 1 | 2005 | 794 | 0.010 |
Why?
| Reference Values | 1 | 2003 | 742 | 0.010 |
Why?
| Walking | 1 | 2005 | 422 | 0.010 |
Why?
| Base Sequence | 2 | 1995 | 2118 | 0.010 |
Why?
| Isoelectric Point | 1 | 1980 | 22 | 0.010 |
Why?
| Matched-Pair Analysis | 1 | 2000 | 33 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 2002 | 854 | 0.010 |
Why?
| Cell Division | 1 | 2002 | 759 | 0.010 |
Why?
| Tumor Necrosis Factor-alpha | 1 | 2005 | 1134 | 0.010 |
Why?
| Biological Assay | 1 | 1980 | 113 | 0.010 |
Why?
| Ovarian Neoplasms | 1 | 2004 | 388 | 0.010 |
Why?
| Renal Dialysis | 1 | 2003 | 369 | 0.010 |
Why?
| Internet | 1 | 2004 | 596 | 0.010 |
Why?
| Cyclothymic Disorder | 2 | 1976 | 3 | 0.010 |
Why?
| Aging | 1 | 2009 | 1620 | 0.010 |
Why?
| Kinetics | 1 | 2002 | 1550 | 0.010 |
Why?
| Founder Effect | 1 | 1998 | 13 | 0.010 |
Why?
| Severity of Illness Index | 1 | 2006 | 2539 | 0.010 |
Why?
| Depression | 2 | 1976 | 1133 | 0.010 |
Why?
| Death Certificates | 1 | 1997 | 30 | 0.010 |
Why?
| Accidents | 1 | 1997 | 38 | 0.010 |
Why?
| Malpractice | 1 | 1997 | 37 | 0.010 |
Why?
| Dibenzocycloheptenes | 1 | 1976 | 2 | 0.010 |
Why?
| Ataxia Telangiectasia Mutated Proteins | 1 | 1996 | 63 | 0.010 |
Why?
| Fluspirilene | 1 | 1976 | 1 | 0.010 |
Why?
| Penfluridol | 1 | 1976 | 1 | 0.010 |
Why?
| Fluphenazine | 1 | 1976 | 5 | 0.010 |
Why?
| Therapeutic Equivalency | 1 | 1976 | 18 | 0.010 |
Why?
| Nail-Patella Syndrome | 1 | 1976 | 1 | 0.010 |
Why?
| Remission, Spontaneous | 1 | 1976 | 37 | 0.010 |
Why?
| Diagnostic Errors | 1 | 1997 | 148 | 0.010 |
Why?
| Haloperidol | 1 | 1976 | 35 | 0.010 |
Why?
| ABO Blood-Group System | 1 | 1976 | 32 | 0.010 |
Why?
| Costa Rica | 1 | 1995 | 16 | 0.010 |
Why?
| Paranoid Disorders | 1 | 1975 | 2 | 0.010 |
Why?
| Hallucinations | 1 | 1975 | 30 | 0.010 |
Why?
| Cause of Death | 1 | 1997 | 362 | 0.010 |
Why?
| Genes | 1 | 1995 | 224 | 0.010 |
Why?
| Long-Term Care | 1 | 1975 | 77 | 0.010 |
Why?
| Delayed-Action Preparations | 1 | 1975 | 159 | 0.010 |
Why?
| Hybrid Cells | 1 | 1993 | 49 | 0.010 |
Why?
| Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 1993 | 15 | 0.010 |
Why?
| DNA, Complementary | 1 | 1993 | 257 | 0.010 |
Why?
| In Situ Hybridization | 1 | 1993 | 293 | 0.010 |
Why?
| Cells, Cultured | 1 | 1980 | 3890 | 0.010 |
Why?
| Tomography, X-Ray Computed | 1 | 2002 | 2269 | 0.010 |
Why?
| Turkey | 1 | 1992 | 15 | 0.010 |
Why?
| Chromosome Banding | 1 | 1992 | 21 | 0.010 |
Why?
| Blotting, Southern | 1 | 1992 | 68 | 0.010 |
Why?
| Ataxia | 1 | 1992 | 35 | 0.010 |
Why?
| Drug Therapy, Combination | 1 | 1975 | 954 | 0.010 |
Why?
| Microcephaly | 1 | 1992 | 51 | 0.010 |
Why?
| Suicide | 1 | 1997 | 502 | 0.010 |
Why?
| Retrospective Studies | 1 | 2006 | 12515 | 0.010 |
Why?
| Wounds and Injuries | 1 | 1997 | 723 | 0.010 |
Why?
| Cataract | 1 | 1992 | 185 | 0.010 |
Why?
| Cysticercosis | 1 | 1969 | 3 | 0.010 |
Why?
| Diagnosis, Differential | 1 | 1992 | 1340 | 0.000 |
Why?
| Brain Diseases | 1 | 1969 | 124 | 0.000 |
Why?
| Adjustment Disorders | 1 | 1976 | 5 | 0.000 |
Why?
| Psychophysiologic Disorders | 1 | 1976 | 10 | 0.000 |
Why?
| Neurocognitive Disorders | 1 | 1976 | 23 | 0.000 |
Why?
| Computers | 1 | 1976 | 60 | 0.000 |
Why?
|
|
Lange's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|